Tenaya Therapeutics Statistics
Total Valuation
TNYA has a market cap or net worth of $168.70 million. The enterprise value is $110.94 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TNYA has 79.22 million shares outstanding. The number of shares has increased by 18.54% in one year.
Current Share Class | 79.22M |
Shares Outstanding | 79.22M |
Shares Change (YoY) | +18.54% |
Shares Change (QoQ) | +0.53% |
Owned by Insiders (%) | 1.18% |
Owned by Institutions (%) | 44.03% |
Float | 55.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.56 |
P/TBV Ratio | 1.56 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.27, with a Debt / Equity ratio of 0.13.
Current Ratio | 5.27 |
Quick Ratio | 4.91 |
Debt / Equity | 0.13 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -84.49% and return on invested capital (ROIC) is -50.46%.
Return on Equity (ROE) | -84.49% |
Return on Assets (ROA) | -45.94% |
Return on Capital (ROIC) | -50.46% |
Revenue Per Employee | n/a |
Profits Per Employee | -$837,343 |
Employee Count | 140 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.00% in the last 52 weeks. The beta is 2.35, so TNYA's price volatility has been higher than the market average.
Beta (5Y) | 2.35 |
52-Week Price Change | +12.00% |
50-Day Moving Average | 2.01 |
200-Day Moving Average | 3.55 |
Relative Strength Index (RSI) | 49.15 |
Average Volume (20 Days) | 5,348,419 |
Short Selling Information
The latest short interest is 5.24 million, so 6.62% of the outstanding shares have been sold short.
Short Interest | 5.24M |
Short Previous Month | 4.88M |
Short % of Shares Out | 6.62% |
Short % of Float | 9.51% |
Short Ratio (days to cover) | 8.19 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -122.74M |
Pretax Income | -120.74M |
Net Income | -117.23M |
EBITDA | -114.18M |
EBIT | -122.74M |
Earnings Per Share (EPS) | -$1.44 |
Full Income Statement Balance Sheet
The company has $79.47 million in cash and $14.54 million in debt, giving a net cash position of $64.93 million or $0.82 per share.
Cash & Cash Equivalents | 79.47M |
Total Debt | 14.54M |
Net Cash | 64.93M |
Net Cash Per Share | $0.82 |
Equity (Book Value) | 112.60M |
Book Value Per Share | 1.42 |
Working Capital | 69.15M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$94.04 million and capital expenditures -$1.22 million, giving a free cash flow of -$95.25 million.
Operating Cash Flow | -94.04M |
Capital Expenditures | -1.22M |
Free Cash Flow | -95.25M |
FCF Per Share | -$1.20 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |